Previous studies have established that adenovirus 2/5 early region 1B (Ad E1B) 58K protein binds p53 strongly and co-localizes with it to cytoplasmic dense bodies whilst the homologous Ad12E1B54K protein binds only weakly and co-localizes primarily to the nucleus in Ad12E1 transformed cells. We have used these properties of the E1B proteins from dierent viral serotypes to map the p53 binding site on the Ad2/5 protein. A set of chimaeric genes was constructed containing dierent proportions of the Ad12 and Ad2E1B DNA. These, together with Ad12E1A and E1B19K DNA, were transfected into baby rat kidney cells and transformed lines isolated. From an examination of the properties of these Ad12/Ad2E1B fusion proteins in co-immunoprecipitation and subcellular localization experiments it has been concluded that the p53 binding site on Ad2E1B58K protein lies between amino acids 216 and 235 and that the homologous region on Ad12E1B54K protein also binds p53. In addition, a unique nuclear localization signal is located on Ad12E1B54K between residues 228 and 239. We suggest that primary structure dierences in these regions of the Ad2 and Ad12E1B proteins are responsible for the dierent subcellular localizations in AdE1 transformants.
Introduction
Transfection of adenovirus early region 1 (E1) DNA into rodent and human cells in culture results in the generation of transformed foci which can be readily established into permanent cell lines (reviewed by Bernards and van der Eb, 1984; Gallimore et al., 1985a) . The E1 region contains two transcription blocks ± E1A and E1B (Boulanger and Blair, 1991) . The E1A proteins are essential for transformation (Boulanger and Blair, 1991; Bayley and Mymryk, 1994) and may, on occasion, transform cells in the absence of co-operating oncogenes (Houweling et al., 1980; Gallimore et al., 1985b) . It is generally considered that this activity of E1A is attributable to its interaction with important cellular components, many of which are involved in transcriptional regulation, such as pRb and the related p107 and p130, p300/CBP and the C-terminal binding protien (Boulanger and Blair, 1991; Bayley and Mymryk, 1994; Moran, 1994) .
The E1B region has no transforming capability of its own but is able to increase the transformation eciency of E1A many fold (van den Elsen et al., 1983; Montell et al., 1984; Gallimore et al., 1985b) . It should be noted, however, that Ad12E1B54K protein alone can extend the life span of human cells in culture without immortalizing them (Gallimore et al., 1997) . The properties of the proteins encoded by the E1B region are less well understood than are those of E1A. However, a certain amount of data is available. The smaller, E1B19K protein in common with other viral proteins such as Epstein-Barr virus BHRF1 (Henderson et al., 1992) serves as a cell survival factor being able to neutralize the p53-mediated apoptosis induced by E1A (Rao et al., 1992; Debbas and White, 1993) . This may be due to the recently described binding to Bax (Han et al., 1996) , although a number of other protein-protein interactions occur (for example, Boyd et al., 1995) .
The larger E1B proteins in Ad2/5 and Ad12 are of 58K and 54K molecular weight respectively. The role of the Ad2/5 component during viral infection is reasonably well understood. It acts on late viral mRNAs after transcription but before translocation from the nucleus (Babiss and Ginsberg, 1984; Babiss et al., 1985; Pilder et al., 1986) . This activity requires association with the AdE4ORF6 34K protein (Sarnow et al., 1984; Halbert et al., 1985; Ornelles and Shenk, 1991) . It appears that these proteins probably bind a cellular factor required for mRNA export and together transport it to the site of viral replication and transcription (Ornelles and Shenk, 1991) . This has the joint eects of favouring viral mRNA processing and limiting host cell mRNA metabolism. It has recently been shown that in isolation Ad5E1B58K protein located to the cytoplasm of transfected cells but in complex with E4ORF6 was found largely in the nucleus (Goodrum et al., 1996) . This localization was cell species speci®c, occurring in primate but not in mouse and rat cells (Goodrum et al., 1996) . The Ad5E1B protein contains no nuclear localization signal (NLS) (Goodrum et al., 1996; Dobbelstein et al., 1997) , whereas E4ORF6 contains an arginine-rich nuclear retention sequence which probably also acts as an NLS (Goodrum et al., 1996; Dobbelstein et al., 1997) . Furthermore, it has recently been shown that the Ad5E1B58K-E4ORF6 complex serves as a nucleocytoplasmic transporter for viral mRNAs, shuttling between the cytoplasm and nucleus (Dobbelstein et al., 1997) . The movement is largely regulated by the E4ORF6 protein which contains a nuclear export sequence similar to that found in the rev and rex retroviral proteins. Little evidence is available on the activity of the Ad12E1B54K protein during viral infection but it is believed to function in a similar manner.
During transformation the mode of action of the larger E1B proteins appears to be rather dierent. Of primary importance is their ability to neutralize the activity of the increased levels of p53 found in AdE1 transformed cells. In the case of the Ad2/5 E1B proteins this appears to be achieved through direct protein-protein interaction (Sarnow et al., 1982) with the transcriptionally inactive complex being sequestered to large cytoplasmic dense bodies (Zantema et al., 1985a,b; Blair-Zajdel and Blair, 1988) . In the case of Ad12 the anity of the E1B54K protein for p53 appears to be appreciably less with only relatively small amounts of the complex being demonstrable by coimmunoprecipitation techniques (Grand et al., 1994) . In these Ad12E1 transformed cells p53 is detectable in the nucleus as is much of the viral 54KE1B protein, although a proportion locates to the cytoplasm (Zantema et al., 1985a,b; Mak et al., 1988; Grand et al., 1993) . Interestingly, both the larger Ad5 and Ad12E1B proteins are able to inhibit the ability of p53 to transactivate other genes (Yew and Berk, 1992) . Apart from the properties of Ad2/5 and Ad12 larger E1B proteins discussed above, there appear to be notable dierences in their abilities to induce tumours in conjunction with AdE1A. Of particular interest is the observation that the virus serotype of the E1B gene determines the tumorigenicity of AdE1 transformed cells injected into immunocompromized rodents (Bernards et al., 1982; Bernards and van der Eb, 1984) . Thus when Ad5E1 transformed rat cells were introduced into nude mice half of the animals developed tumours but when Ad12E1B54K substituted for the Ad5E1B58K all of the animals succumbed (Bernards and van der Eb, 1984) . It should be noted, however, that the ability of AdE1 to transform baby rat kidney cells is dependent on the serotype of the E1A gene with little dierence between Ad12E1B54K and Ad5E1B58K proteins (Bernards et al., 1982) .
These dierences and similarities between the properties of the Ad2/5 and Ad12E1B proteins raise a number of interesting questions. For example, do the proteins have roles in the transformation process distinct from their ability to neutralize p53 activity and is this neutralization achieved by a similar mechanism in the two virus serotypes? In addition, it is not clear what importance should be attached to the dierences observed in sub-cellular localization of p53 in Ad2/5 and Ad12 transformed cells.
The binding site on p53 for the AdE1B58K protein has been closely mapped to an area around amino acids 23 ± 27 (Lin et al., 1994) . However, the area of interaction on the viral protein has only been loosely de®ned by mutational analysis (amino acids 224 ± 354, Kao et al., 1990) . No information has previously been available as to whether comparable amino acid sequences are involved in the interaction of the Ad12 protein. In the study presented here we have used chimaeric 54K/58K proteins to de®ne the p53 binding site on Ad2/5E1B58K much more closely. In addition, we have examined whether a similar site exists on the Ad12 homologue. Signi®cantly, we also suggest that nuclear location of the Ad12E1B54K protein is determined by a speci®c localization signal which is absent from the Ad2/5E1B58K protein.
Results

Cell lines expressing Ad12/Ad2 E1B fusion proteins
RecA-mediated recombination of the DNA encoding Ad2E1B58K protein with Ad12E1 DNA in bacteria was used to generate plasmids containing Ad12E1A and Ad12E1B19K genes together with Ad12/ Ad2E1B54K/58K fusions as described in the Materials and methods. These DNA constructs were transfected into HLBRK cells and transformed lines established. Adenovirus DNA was sequenced to con®rm the presence of genes encoding the Ad12E1A and E1B19K proteins and to determine the precise dimensions of the Ad12E1B54K and Ad2E1B58K sections in the E1B gene fusions. Cell lines expressing dierent fusion proteins were chosen for further study and these are summarized in Figure 2 . Residue numbers stated are appropriate to the protein fragment under consideration ± thus at the point of crossover from the Ad12 to the Ad2E1B there is a loss of consecutivity in the numbering ± this does not mean that there is a loss of amino acid sequence between the two proteins ( Figure 2b ). Amino acid numbers for the Ad12E1B54K protein are given in normal type and for the Ad2E1B58K protein in italics.
Unfortunately, attempts to produce complementary cell lines containing the N terminal portion of Ad2E1B58K protein fused to the C terminus of Ad12E1B54K protein have proved unsuccessful. This appears to be due to artefactual recombination events.
Analysis of protein expression in transfected cell lines
Following transfection of the crossover plasmids into HLBRKs and the establishment of permanent cell lines the expression of the Ad12/Ad2E1B fusion protein was examined by Western blotting using the antibody XPH9 which is known to bind to an amino acid sequence located close to the N terminus of Ad12E1B54K (Merrick et al., 1991) . This epitope is common to all of the constructs used in these experiments (XPH9 does not cross-react with intact Ad2/5E1B58K protein). It can be seen that there was considerable variation in the level of expression of the fusion proteins (Figure 3 Figure 3 demonstrates expression of E1B fusion protein in cell lines XA39 (track 5) and XE77 (track 7) (data not shown). No AdE1B protein was seen, under any circumstances, in cell lines XE7 and XE69. All cell lines express Ad12E1A and Ad12E1B19K protein (data not shown).
It has previously been noted that there was a direct correlation between level of expression of the larger AdE1B protein and p53 (Grand et al., 1993) following transfection into A549 cells or primary cells (Gallimore et al., 1997) . Thus the samples were blotted for p53 and the results are shown in the lower panel of Figure 3 . It can be seen that there was a marked similarity in the patterns shown in the two Western blots con®rming that Ad12E1B protein can play a major role in the regulation of p53 expression as has been suggested previously (Grand et al., 1996) .
Subcellular localization of Ad2/Ad12E1B fusion proteins
As mentioned in the Introduction, the most obvious dierence between Ad5E1 and Ad12E1 transformed cells is that in the former case both the Ad5E1B58K protein and p53 are present in cytoplasmic dense bodies whilst in Ad12 transformed cells p53 is nuclear with the E1B54K protein being largely present in the nucleus but with smaller amounts spread throughout the cytoplasm. These previous observations are con®rmed by the photomicrographs of representative Ad2 or Ad12E1 transformed BRK cell lines shown in Figure 4a . This illustration also con®rms that the monoclonal antibodies used to detect the larger E1B proteins are virus serotype-speci®c. No reactivity can be seen in panels B and F whilst panels C and E show the respective distribution of wt58K protein (Ad2) and wt54K protein (Ad12).
Staining was also carried out on the rat lines expressing the AdE1B fusion proteins using pAb421 to detect p53 and XPH9 to detect the N-terminus of Ad12E1B54K present in all of the Ad12/Ad2 fusion proteins. Table 1 summarizes all of the immunofluorescence data accumulated from studies carried out on at least three independent cell lines per chimaeric plasmid construct. In agreement with the Western blotting data, no Ad12E1B54K protein could be detected in cell lines produced following transfection with plasmids XE69, XB47, XB100 or XE7. BRK cell lines generated by XA39 were phenotypically Ad2-like for both p53 (panel D) and E1B (panel H) staining whilst in XE77 cells E1B was located entirely in the cytoplasm (panel G) although p53 staining was seen as large cytoplasmic aggregates in all cells but with weak diuse nuclear staining in some cells (panel C) (overall less than 1%). Panel C was chosen to give a comparison of the intensity of p53 staining (compare panels A and B) but rather exaggerates the proportion of cells with nuclear p53. For XF11 (panel B) and XF6 (data not shown) cells p53 staining was similar to that seen for XE77 but the number of cells with strong diuse nuclear¯uorescence was considerably greater and E1B staining was a mixture of the Ad2 and Ad12 patterns. Cell lines derived using plasmids XB32, XA2, XE8, and XE56 (data not shown) and XF3 showed a distribution of both p53 (panel A) and E1B (panel E) identical to that seen in the Ad12E1BRK cell line (Figure 4a , panels D and E). The increase in the proportion of cells in a culture with p53 nuclear¯uorescence and the intensity of that nuclear¯uorescence correlates well with a decreased anity of the E1B protein for p53 (see Table 1 and next section). We conclude on the basis of these data (summarized in Table 1 ) that the subcellular localization of p53 in AdE1 transformed cells is dependent on both the sequence and the localization of the larger AdE1B protein. From a consideration of the dimensions of Ad12 and Ad2 portions of the E1B Rec A-mediated recombination to produce Ad12E1B54K/ Ad2E1B58K fusion proteins using plasmid pPOD 10.3 ± 58K. Recombination takes place between the 58K and 54K genes as indicated, giving rise to daughter plasmids with either the E1B fusion and the kanamycin resistance gene or E1A, E1B fusion and the ampicillin resistance gene fusion proteins, we also conclude that translocation of the Ad12E1B54K protein itself to the nucleus appears to be governed by an amino acid sequence between 202 and 239 with a major determinant between residues 228 and 239.
Although previous studies had indicated the presence of Ad12E1B54K protein in the nucleus of Ad12E1 transformed cells they had not provided any more speci®c information regarding the sub-nuclear localization. However, it can be seen from the Kao et al. (1990) is shaded. ..., deletions introduced to the sequence to give best alignment between the two proteins; |, identical amino acids in the two sequences; :, very similar amino acids; ., broadly similar amino acids photomicrographs shown in Figure 4a panel E and Figure 4b panel E that Ad12E1B54K protein localizes to the spindle mechanism in dividing cells. Similar results were also obtained with Ad12E1 transformed human cells (data not shown). No evidence of association of Ad2/5E1B58K protein with the spindle in Ad2/5E1 transformants was obtained. The significance of these observations will have to await further investigation but it seems possible that this represents a novel function for the Ad12 protein.
Binding of AdE1B fusion proteins to p53
It has been known for many years that Ad5E1B58K protein binds p53 strongly (Sarnow et al., 1982) , whilst the Ad12 homologue binds much more weakly (Grand et al., 1994) . It would be expected therefore that when the Ad2/5E1B58K p53 binding site is incorporated into the Ad12E1B sequence the fusion protein would become a`strong' p53 binder. With this in mind, a variety of cell lines shown in Figures 2 and 3 were examined for the ability of their Ad12/Ad2E1B fusion proteins to bind p53. Volumes of cell lysates used in these co-immunoprecipitation experiments were based on the total AdE1B protein present (determined by densitometric scanning of Western blots similar to those shown in Figure 3 ) to compensate for variations in level of expression such that an identical amount of Ad12/2E1B fusion protein was immunoprecipitated for Staining for p53 using pAb421 is shown in panels A and D, for Ad12E1B54K using XPH9 in panels B and E and for Ad2E1B58K using 2A6 in panels C and F. The bar is 10 mm. (b) Confocal images from representative BRK cell lines expressing Ad12/2E1B fusion proteins as follows: panels A and E, XF3; panels B and F, XF11; panels C and G, XE77 and panels D and H; XA39. Panels A, B, C and D stained for p53 using pAb421 and panels E, F, G and H stained for 54K/ 58K protein using XPH9. The bar is 10 mm 
was detected by Western blotting using the antibody CM1 (a representative blot is shown in Figure 5a ). As there were very large dierences in AdE1B expression ( Figure 3) and therefore in the volumes of lysates used a series of co-immunoprecipitation experiments was carried out. Densitometric scanning (using a BioRad model GS-690 Imaging Densitometer) of the Western blots allowed the relative levels of co-precipitated p53 to be determined for cell lines within a single experiment. It was possible to relate results obtained from dierent experiments by the inclusion, in each set of immunoprecipitates, of appropriate volumes of lysates of XA2, XF11 and Ad12E1HER2 cells. (All results were normalized to values obtained for these cell lines).
Relative levels of p53, co-immunoprecipitated with the AdE1B protein using the XPH9 antibody, in the panel of cell lines, determined by densitometric scanning of Western blots, are presented in Figure  5b . It can be seen from these data that much more p53 was present after precipitation from cells expressing an E1B fusion protein which contained a fragment of the Ad2 protein extending N-terminal from amino acid 236 up to 202 (i.e. cell lines XA39 and XE77). However, when the Ad12E1B portion of the fusion protein extends as far as amino acid 221 (cell line XF11) the p53 bound to the fusion protein is appreciably reduced. The E1B fusion proteins which contain amino acids 240 to the 280 of the Ad2 sequence appear to have a slightly increased anity for p53 (over wt Ad12E1B54K) but those with an Ad2 portion which extends from residue 280 to the C-terminus behave essentially like the intact Ad12E1B54K protein. We conclude on this basis (summarized in Table 1 ) that the major portion of the p53 binding site on Ad2E1B58K protein is contained between amino acids 216 and 235.
Disruption of p53 binding to the larger AdE1B proteins with synthetic peptides Synthetic peptides can be internalized by cells from the tissue culture medium if they have an additional amino acid sequence, at either end, equivalent to part of the homeodomain of the transcription factor Antennapedia. This approach has been used in these studies to introduce a peptide equivalent to the proposed p53 binding site on the AdE1B protein into cells in an attempt to disrupt the interaction. In an initial study synthetic peptides equivalent to the Ad2E1B58K protein between amino acids 219 and 233 (peptide 2 in the Materials and methods), Ad12E1B54K protein between amino acids 205 and 221 (peptide 1 in the Materials and methods) and a control peptide (peptide 3) were added at dierent concentrations to lysates from Ad5E1HEK293 and Ad5HER911 cells. The Ad5E1B58K protein was immunoprecipitated with antibody 2A6 and the amount of co-precipitated (i.e. bound) p53 determined by Western blotting (Figure 6a and data not shown for Ad5E1HEK293 and Ad5HER911 cells respectively). Densitometric scanning of Western blots has allowed the relative levels of interacting proteins to be determined (Figure 6b ). It can be seen that whilst complex could be detected in all samples there was a distinct reduction in coprecipitated p53 at higher peptide concentrations, suggesting that both peptides competed for the binding site on p53. No disruption of complex was seen with a control peptide (Figure 6a) . In a further a b Figure 5 Co-immunoprecipitation of p53 with AdE1B fusion proteins. Cell lines expressing AdE1B fusion proteins were harvested and solubilized. Aliquots from lysates were subjected to Western blotting for E1B fusion protein detected with antibody XPH9. Densitometric scanning of these blots allowed the relative level of expression to be determined. Using appropriate volumes of lysates, containing equal amounts of E1B fusion protein, immunoprecipitations were carried out with antibody XPH9. Coprecipitating (i.e. bound) p53 was determined by Western blotting using antibody CM1. A representative blot showing some of the cell lines used is shown in panel A. Cell lines shown: track 1, XB32; 2, XE8; 3, XA39; 4, XF3; 5, XF11; 6, XA2; 7, Ad12E1HER2. Densitometric scanning was used to determine the relative levels of co-precipitated p53 and these results are presented in full as a histogram (panel B) study peptides equivalent to the proposed p53 binding sites on both the Ad5E1B58K and the equivalent sequence in Ad12E1B54K proteins were added to Ad5E1 and Ad12E1 transformed cells (100 mg/ml in the tissue culture medium). After 16 h cells were harvested and the AdE1B proteins were immunoprecipitated, additional peptide having been added to a portion of each lysate. Co-precipitated p53 was determined by Western blotting (Figure 6c,d) . It can be seen that pre-incubation of cells with peptide reduced the p53 bound to the AdE1B protein for both cell lines but more markedly for Ad12E1HER2 cells. Further reduction in the complex was achieved by increasing the peptide concentration in the immunoprecipitation mixture. Similar results to those shown in Figure 6c ,d were obtained with the Ad2XhoC/HLBRK line 4 and Ad12EcoC/HLBRK line 3 and Ad12E1HER10 cell lines (data not shown). On the basis of these data we conclude that the p53 binding sites on the AdE1B proteins are contained between amino acids 205 and 221 and 219 and 233 on the Ad12 and Ad5 proteins respectively.
Discussion
The roles of the larger AdE1B proteins in viral infection and DNA-mediated transformation appear to be quite distinct. In the former case, in Ad2/5 at least, AdE1B58K protein binds to E4ORF6 and, together with cellular factors, regulates the subcellular distribution of the late viral mRNAs (Leppard and Shenk, 1989; Ornelles and Shenk, 1991; Goodrum et al., 1996; Dobbelstein et al., 1997) . In transformed cells, in the absence of E4ORF6, the major role of Ad5E1B58K and Ad12E1B54K proteins seems to be to act as transcriptional repressors rendering the major portion of the cellular p53 transcriptionally inactive (Yew and Berk, 1992; Yew et al., 1994) . Up to now no evidence has been presented to suggest that these proteins in the absence of E4 have any eect on RNA processing.
Ad2/5E1B58K and Ad12E1B54K proteins can repress transcription when directed to DNA in vitro independently of any interaction with p53 (Yew et al., 1994; Parkhill et al., unpublished results). However, in vivo both the viral proteins are targeted to p53-responsive genes, probably through direct binding to p53. Ad5E1B58K can bind strongly to p53 with this complex being localized to cytoplasmic dense bodies whereas Ad12E1B54K binds weakly and is present, with p53, largely, although not entirely, in the nucleus of transformed cells. We have used these dierences in anity as the basis of a study aimed at locating the p53 binding site on the Ad2 protein. To this end chimaeric genes were constructed comprising the 5' end of the Ad12E1B gene and increasing complementary portions of the 3' end of the Ad2E1B gene such that the overall structure and dimensions of the protein remained the same. This was considered to be essential as we have previously found that even small truncations and deletions of the Ad12E1B54K protein render it particularly unstable Byrd et al., 1988; and our unpublished observations) . After transfection of these chimaeric genes in conjunction with Ad12E1A and Ad12E1B19K into BRK cells permanent lines were established and properties of the AdE1B fusion proteins examined against this cellular background. From a consideration of the data presented in Figure 4 (summarized in Table 1 ) it is apparent that there are nuclear localization signals between amino acids 202 and 239 on the Ad12E1B54K protein which are absent from the Ad2 homologue. These localization signals are quite distinct from any ability to form a strong complex with p53 ( Figure 5 ). It appears that two NLSs can be distinguished. The presence of the ®rst weak sequence, between amino acids 202 and 228 (cell lines XE77, XF11 and XF6) gives rise to an AdE1B fusion proteins which is divided between the nucleus and cytoplasm. From a consideration of the amino acid sequence ( Figure 2B ) it is probable that the arginines present at positions 199, 203, 205 and 225 may well be involved, with particular importance being attached to arginine 205, the only one which is not conserved in Ad2E1B58K protein.
Since the AdE1B fusion proteins which contain the additional Ad12 sequence between amino acids 229 and 238 are entirely nuclear we conclude that an additional, more potent NLS is present in this area. We suggest that the two basic amino acids (K230 and K232, Figure 2B ), possibly in conjunction with R225, which are not present in the Ad2 protein (replaced by N and S) are responsible for this localization. Thus, it appears that the Ad2/5E1B58K protein which is cytoplasmic (Goodrum et al., 1996) is responsible for the cytoplasmic localization of p53 in Ad2/5E1 transformed cells. Quite why the p53-Ad5E1B58K complex does not localize to the nucleus is not clear particularly as E4ORF6-Ad5E1B58K is plainly nuclear (Goodrum et al., 1996) and p53 carries nuclear localization signals. It is possible that amino acid sequences in the E1B protein favour cytoplasmic retention such that they override any NLS on p53 but are not eective in the Ad5E1B58K-E4ORF6 complex. The observation that Ad12E1B54K protein is nuclear in the presence (Zantema et al., 1985a; Mak et al., 1988; Blair-Zajdel and Blair, 1988) and absence (Gallimore et al., 1997) of other Ad12E1 proteins has favoured the view that a speci®c NLS is present. Whether this means that Ad12E1B54K functions dierently to the Ad5 homologue in RNA processing during viral infection is open to question. It could, of course, be argued that Ad12E4ORF6 might play a dierent role to the analogous Ad5 protein as it would not be required for nuclear localization of Ad12E1B54K protein. The absence of sequence homology between Ad5E4ORF6 and Ad12E4ORF6 (Sprengel et al., 1995) would favour this view.
The data presented in Figure 5 strongly suggest that the binding site for p53 on Ad2E1B58K protein is located in the region between amino acids 216 and 236. It is presumed that the presence of more of the Ad2 sequence in the fusion protein present in XA39 cells, which appears to bind p53 slightly more strongly than the XE77 protein, allows the binding site to form a three dimensional structure closer to that present in the intact Ad2 protein. It is not possible to determine whether the XA39E1B protein binds p53 as well as wt58K protein because the same antibody cannot be used to immunoprecipitate both Ad5E1B58K and Ad12/Ad2 fusion protein. The suggested binding site has been, at least partially, con®rmed by the observation (Figure 6 ) that a peptide identical to that amino acid sequence interferes with complex formation between Ad5E1B58K and Ad12E1B54K and p53 both in vitro and, to a lesser extent, in vivo. The observation that high concentrations of peptide are required to disrupt the complex is consistent with the presumed high anity/strong binding of Ad5E1B58K for p53. Partial disruption of the complex in Ad5E1 and Ad12E1 transformed cells with a peptide identical to the homologous site on Ad12E1B54K suggests that this is responsible for the observed weak binding between the Ad12 protein and p53 (Figure 6a,b and d) .
It is possible that additional weak p53 binding sites are present on both the Ad5 and Ad12E1B proteins closer to the N-terminus. If this were the case it might explain the inability of the synthetic peptides to disrupt totally the weak interaction between Ad12E1B54K protein and p53. The observation that Ad2/5 and Ad12 peptides are equally eective in disruption of the interaction of Ad5E1B58K with p53 ( Figure 6a ,b and c) is not really consistent with strong binding by Ad5E1B58K and weak binding by Ad12E1B54K proteins. On this basis we suggest that other conformational restraints may well exist within the Ad12E1B54K protein reducing its anity for p53 such that`strong' binding does not occur. However, there is a much more marked reduction in the AdE1B : p53 complex in Ad12E1 transformed cells than in Ad5E1 transformants after addition of peptides in vivo (compare Figure 6c and d) which is consistent with a weaker interaction in Ad12 transformed cells. Fifty-®ve per cent of the amino acids in the proposed p53 binding sites (residues 216 ± 235 on Ad2E1B58K and residues 202 ± 221 on Ad12E1B54K) are identical between the Ad2 and Ad12 proteins with 75% of the residues considered to be highly conserved. These ®gures are representative of proportions in the proteins as a whole. A determination of speci®c amino acids involved in p53 binding will have to await further study. About half of the p53 binding site on Ad2/ 5E1B58K protein proposed here falls within the large area (amino acids 224 ± 354) suggested by Kao et al. (1990) to encompass the site of interaction. On this basis it might be suggested that the very short sequence between residues 224 and 236 on Ad2E1B58K is responsible for p53 binding. However, it is worth noting that a variety of point mutations throughout Ad5E1B58K protein drastically reduce or abolish its ability to bind p53 (Yew et al., 1994) . Thus, for example, substitutions at H17, H180, A262, H326, S380 and F484 all interfere with complex formation. We suggest that these data con®rm the inherent instability of the viral protein rather than directly highlight points of contact for p53 on Ad5E1B58K.
The dierence in subcellular localization between the Ad2/5 and Ad12E1B proteins raises an interesting point. In Ad12E1 transformants p53 transcriptional activity is very low (Yew and Berk, 1992; Grand et al., 1996) presumably due to the presence of Ad12E1B54K protein in the nucleus, which probably represses activity by the mechanism outlined by Yew et al. (1994) . However, in Ad5E1 transformants the localization of the complex in the cytoplasm suggests that the transcriptional repression activity of the Ad5E1B58K protein never comes into play. Although our knowledge of the mode of action of the larger AdE1B proteins has increased appreciably over recent years that particular important question remains unanswered. It is interesting to note however that the addition of both the Ad2 and Ad12E1B protein peptides (peptides 1 and 2, Materials and methods) to Ad5 and Ad12E1 transformants results in an increase in p53 transcriptional activity, determined with a transfected CAT reporter construct. (F Hutton and RJA Grand, unpublished data) .
In summary, we have demonstrated here, using Ad2/ Ad12E1B fusion proteins, the presence of probable nuclear localization signals in the amino acid sequence of Ad12E1B54K protein between amino acids 202 and 239, which are absent from the Ad2/5 homologue. In addition, the binding site for p53 on Ad2/5E1B58K protein has been mapped to an area between amino acids 216 and 236.
Materials and methods
The generation of the Ad12E1B54K/Ad2E1B58K chimaeric genes Chimaeric Ad1254K/Ad258K genes were produced by recA-mediated recombination in bacterial cells. Plasmids which contain an intact Ad12E1A, Ad12E1B19K and the 5' end of Ad12E1B54K open reading frame (ORF) fused to various portions of the 3' end of the Ad2E1B58K ORF were generated using the recombination plasmid pPOD6 (DA Rouch and NL Brown, personal communication). The parent plasmid pPod 10.3 ± 58K ( Figure 1A ) was produced 5, 350 mg. (b) Densitometric scans of Western blots after disruption of Ad5E1B58K : p53 complex in vitro. Lysates from Ad5E1HEK293 (i) and (ii) and Ad5HER911 (iii) and (iv) cells were incubated with peptides equivalent to the p53 binding sites on Ad5E1B58K protein (peptide 2) (i) and (iii) or Ad12E1B54K protein (peptide 1) (ii) and (iv) as in a. Ad5E1B58K protein was immunoprecipitated with 2A6 and co-precipitated p53 detected by Western blotting. Densitometric scanning was used to determine the relative levels of p53. Results shown are the mean of at least three experiments+standard deviation. (c) Disruption of Ad5E1B58K binding to p53 in vivo. Ad5E1HEK293 cells in culture were treated with Ad12E1B54K peptide (peptide 1) or Ad5E1B58K peptide (peptide 2) as described. After harvesting and solubilization lysates were divided in two. Additional peptide (100 mg) was added to one half. by cloning the entire Ad12E1 region into the EcoRI site and Ad2E1B58KORF into the SphI site of pPOD6 respectively. Recombination between Ad12E1B54K and Ad2E1B58K genes was achieved by the following protocol (Figure 1b) . 1 mg of pPOD10.3 ± 58K was transformed into 100 ml of competent E. Coli TG1 cells, the mixture aliquoted (10610 ml) and transformation completed. Each aliquot was incubated in 50 ml L-broth at 378C for 1 h and further incubated overnight in 5 ml of L-broth containing 100 mg/ml ampicillin. (TG1 cells have an intact recA gene which permits recombination between the Ad12E1B54KORF and the Ad258KORF). The overnight cultures were lysed, plasmid puri®cation carried out and the plasmids digested with SalI. This restriction enzyme cuts the parent plasmid pPOD10.3 ± 58K but leaves 54K/ 58K recombinants intact. These digests were transformed into competent TG2 cells, plated on L-agar plates containing 100 mg/ml ampicillin and incubated overnight (TG2 cells have a mutant recA gene and are therefore defective for recombination). Resulting colonies were patched onto plates containing both ampicillin (100 mg/ml) and kanamycin (50 mg/ml) and ampicillin alone and incubated overnight at 378C. Kanamycin-sensitive colonies potentially contain daughter plasmids with 54K/58K crossovers. Plasmids were isolated from cells grown up from the replica colonies derived from the ampicillin plates. The E1B sequence was determined to elucidate the exact region of crossover and to con®rm that no extraneous mutations had been introduced.
Derivation of cell lines expressing Ad12 and Ad2E1B54K/58K chimaeric proteins
Seven to 14-day-old Hooded Lister (HL) rat kidneys were decapsulated, minced with pointed scissors and digested with 2.5 units/ml neutral protease (Dispase II, Boehringer Mannheim) in HEPES DME medium at 378C for 30 min. HL baby rat kidney cells (HLBRK) were pelleted by centrifugation and resuspended in DME plus 8% FCS (4 mls/kidney). Fifty mg of recombinant plasmid in 50 ml of tissue culture grade water was added to 50 ml of 26HEPES DME and placed in an electroporation curvette. To this was added 100 ml of the concentrated HLBRK cell suspension. Electroporation was carried out at 220 V and 960 mF using a BIO-RAD Gene Pulser and the electroported HLBRK cells added to 40 ml of growth medium (HEPES DME supplemented with 8% FCS and 2 mM glutamine). The electroporated HLBRK cells were then gently pipetted several times to maximize dispersion and the cells were dispensed into six 25 cm¯asks. Recombinant plasmid-containing HLBRK cells were incubated at 378C for 4 ± 5 weeks with medium changing every third day. Adenovirus-transformed colonies were identi®ed microscopically, picked with a ®nely drawn Pasteur pipette and established into cell lines as previously described (Gallimore et al., 1985b) .
Additional cell lines used
A number of other Ad-transformed cell lines were used in this study. Ad12E1 human embryo retinoblast (HER) 2 and Ad12E1HER10 cells were produced by transfection of Ad12E1 DNA into human embryo retinoblasts. Ad12EcoC/HLBRK line 3 cells were produced by transfection of Ad12E1 DNA into HLBRK cells. Ad5E1HEK293 and Ad5HER911 (a generous gift from Professor Alex van der Eb, Leiden University), express Ad5E1 proteins. Ad2XhoC/HLBRK line 4 cells were produced by transfection of Ad2E1 DNA (XhoC fragmen) into HLBRK cells. All cells were grown in HEPESbuered DMEM supplemented with 8% FCS and 2 mM glutamine.
Synthetic peptides
Peptides were synthesized using standard f-moc protocols and were puri®ed by HPLC on C 18 reverse phase columns eluted with a gradient (0 ± 100%) of acetonitrile containing 0.1% TFA. Peptides synthesized corresponded to the proposed p53 binding sites on the Ad2 and Ad12E1B58K and 54K proteins linked to the 16 amino acid region of the homeodomain of Antennapedia (the`penetratin' sequence) to facilitate entry into cells (Prochiantz, 1996) . Sequences of the peptides were: (1) ERQIKIWFQNRRMKWKKMRMQGMGPGVVGL-DGITF corresponding to Ad12E1B54K amino acids 205 ± 221; (2) ERQIKIWFQNRRMKWKKMSMINMW-PGVLGMDGV corresponding to Ad2E1B58K amino acids 219 ± 233. The adenovirus sequences are shown in bold. (3) A control peptide corresponding to the C terminus of Ad12E1A linked to the`penetratin' sequence was also synthesized.
Western blotting and immunoprecipitation
For Western blotting studies, cells were washed in cold saline, harvested and solubilized in 9 M urea, 50 mM Tris HCl pH 7.4, 0.15 M b-mercaptoethanol. Proteins (50 mg) were fractionated on polyacrylamide gels run in the presence of 0.1 M Tris, 0.1 M Bicine 0.1% SDS and transferred to nitrocellulose ®lters. Western blots were processed using standard procedures and antigens visualized by ECL (Amersham). Ad12E1B54K protein and the various fusion proteins were detected with the monoclonal antibody XPH9 (tissue culture supernatant diluted 1 : 10) (Merrick et al., 1991) . Ad5E1B58K protein was detected with the antibody 2A6 (diluted 1 : 10) (a generous gift from Professor Arnold Levine, Princeton) and p53 was detected with a rabbit antibody CM1 (diluted 1 : 5000), (a generous gift from Professor David Lane, University of Dundee).
For immunoprecipitation studies cells were washed in cold saline, harvested and solubilized in 20 mM Tris HCl pH 7.3, 0.825 M NaCl, 1% NP40, sonicated and clari®ed by ultracentrifugation at 35K for 30 min. Immunoprecipitation was carried out on the supernatants by the procedure of Paraskeva et al. (1982) except that protein G-agarose (Sigma) was used to bind antibody/antigen complexes, rather than protein A. Immunoprecipitations were carried out using XPH9 tissue culture supernatant (150 ml) for cells containing Ad12E1B54K protein or the fusion proteins or 2A6 (150 ml) for cells containing Ad2/5E1B58K protein. Immunoprecipitated proteins were subjected to SDS ± PAGE and were Western blotted using CM1 antibody against p53.
Immunocytochemistry
Cells were grown on glass multiwell slides and ®xed in acetone/methanol (50 : 50 v/v) for 10 min at 7208C. Slides were pre-incubated for 1 h in 20% heat inactivated goat serum (HIGS) and then incubated in monoclonal antibody (tissue culture supernatant) diluted 1 : 1 in 20% HIGS for 1 h at room temperature. Antigens were visualized using goat anti-mouse Alexa 488 (Molecular Probes, USA). Slides were ®nally mounted in ProLong Antifade reagent (Molecular Probes, USA). Ad12E1B54K protein and fusion proteins were detected with XPH9, Ad5E1B58K protein was detected with 2A6 and p53 with mAb 421 (a generous gift from Professor David Lane, University of Dundee). Confocal microscopy was performed with a Zeiss Axiphot¯uorescence microscope. Images were recorded and analysed with the Biovision software package (ImproVision).
